The heterogeneity of heart failure: Will enhanced phenotyping be necessary for future clinical trial success?

Journal of the American College of Cardiology

Volumn 64, Issue 17, 2014, Pages 1775-1776

  Francis, Gary S ^a   Cogswell, Rebecca ^a   Thenappan, Thenappan ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

cluster analysis; exercise; Key classification; phenotype

Indexed keywords

CARDIOVASCULAR MORTALITY; CLINICAL TRIAL (TOPIC); COMORBIDITY; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HEART EJECTION FRACTION; HEART FAILURE; HOSPITALIZATION; HUMAN; ISCHEMIC CARDIOMYOPATHY; NONISCHEMIC CARDIOMYOPATHY; NOTE; PHENOTYPE; RISK REDUCTION; SURVIVAL RATE; FEMALE; HEART FAILURE, SYSTOLIC; MALE; PATHOLOGY;

FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; MALE;

EID: 84908153218     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.07.978     Document Type: Editorial

References (13)

1. A.S. Go, D. Mozaffarian, and V.L. Roger Executive summary: heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 399 410
2. F. Bursi, S.A. Weston, and M.M. Redfield Systolic and diastolic heart failure in the community JAMA 296 2006 2209 2216
3. A.M. Minino, S.L. Murphy, J. Xu, and K.D. Kochanek Deaths: final data for 2008 Natl Vital Stat Rep 59 2011 1 126
4. M. Gheorghiade, M. Bohm, and S.J. Greene Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial JAMA 309 2013 1125 1135
5. J. Kjekshus, E. Apetrei, and V. Barrios Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261
6. C.M. O'Connor, D.J. Whellan, and K.L. Lee Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial JAMA 301 2009 1439 1450
7. K. Swedberg, J.B. Young, and I.S. Anand Treatment of anemia with darbepoetin alfa in systolic heart failure N Engl J Med 368 2013 1210 1219
8. L. Tavazzi, A.P. Maggioni, and R. Marchioli Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 1231 1239
9. G.S. Francis Where have all the clinical trials gone? J Card Fail 17 2011 701 702
10. T. Ahmad, M.J. Pencina, and P.J. Schulte Clinical implications of chronic heart failure phenotypes defined by cluster analysis J Am Coll Cardiol 64 2014 1765 1774
11. P.R. Burgel, J.L. Paillasseur, and D. Caillaud Clinical COPD phenotypes: a novel approach using principal component and cluster analyses Eur Respir J 36 2010 531 539
12. R. Erro, C. Vitale, and M. Amboni The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients PLoS One 8 2013 e70244
13. S.Y. Park, S. Baek, and S. Kim Clinical significance of asthma clusters by longitudinal analysis in Korean asthma cohort PLoS One 8 2013 e83540